Edding Genor Group Holdings Ltd
06998
Company Profile
Business description
Edding Genor Group Holdings Ltd is a biopharmaceutical company with the vision of China. Its majority therapeutic areas include oncology, autoimmune, cardiovascular, respiratory and anti-infectives. Its drugs includes Vascepa, Mulpleta, Jingzhuda, and Rujianing.
Contact
248 Queen’s Road East
40th Floor, Dah Sing Financial Centre
Wanchai
Hong Kong
HKGSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
Stocks News & Analysis
stocks
AI isn’t an economic moat killer, but it will disrupt industries
How we’re rethinking companies’ competitive advantages in an AI-first world.
stocks
AI lands a blow on some Aussie stocks – yet stands to benefit others
AI is reshaping ASX tech moats - but some are more insulated than others.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,581.80 | 114.80 | -1.32% |
| CAC 40 | 7,726.20 | 60.58 | 0.79% |
| DAX 40 | 22,653.86 | 273.67 | 1.22% |
| Dow JONES (US) | 46,208.47 | 631.00 | 1.38% |
| FTSE 100 | 9,894.15 | 24.18 | -0.24% |
| HKSE | 24,382.47 | 894.85 | -3.54% |
| NASDAQ | 21,946.76 | 299.15 | 1.38% |
| Nikkei 225 | 51,954.73 | 439.24 | 0.85% |
| NZX 50 Index | 12,796.98 | 102.74 | -0.80% |
| S&P 500 | 6,581.00 | 74.52 | 1.15% |
| S&P/ASX 200 | 8,391.80 | 112.80 | -1.33% |
| SSE Composite Index | 3,813.28 | 0.00 | 0.00% |